May 10 |
Relay Therapeutics upgraded by Barclays ahead of data readout
|
May 4 |
Relay Therapeutics First Quarter 2024 Earnings: Beats Expectations
|
May 3 |
Relay Therapeutics GAAP EPS of -$0.62 beats by $0.10, revenue of $10.01M beats by $9.09M
|
May 2 |
Relay Therapeutics Outperforms Revenue Expectations in Q1 2024
|
May 2 |
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
|
May 2 |
Relay Therapeutics GAAP EPS of -$0.62 beats by $0.08, revenue of $10M beats by $9.89M
|
May 2 |
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
|
Apr 25 |
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
|
Apr 11 |
Relay Therapeutics to Participate in Upcoming Investor Conferences
|